The Foxo subfamily of FOX transcription factors plays a variety of roles in a broad assortment of diverse physiological processes including cellular differentiation, tumor suppression, metabolism, cell cycle arrest, cell death and protection from stress. Animal models have proved to be invaluable tools in furthering our understanding of the role of particular genes in complex organismal processes. Multiple animal models in diverse species, including Caenorhabditis elegans, Drosophila. melanogaster and the laboratory mouse, exist for the Foxo family of transcription factors. Foxo genes are highly conserved throughout the evolution and each of these model systems has provided valuable insight into the roles of Foxo factors. Many roles are conserved among the different model organisms. Several Foxo-related animal model systems are reviewed here along with the knowledge gleaned to date from each model system. Oncogene (2008Oncogene ( ) 27, 2345Oncogene ( -2350 doi:10.1038/onc.2008 Keywords: FOXO; FKHR; daf-16; dFoxo; animal models
The recent awarding of the 2007 Noble Prize in Physiology or Medicine to Mario R Capecchi and Oliver Smithies and Sir Martin J Evans for gene targeting in mice (Vogel, 2007) only serves to emphasize the importance of animal models in understanding the role of particular genes in processes such as embryonic development, adult physiology, disease and aging. Organisms used as animal models share the distinctive characteristic that it is possible to manipulate the genome and modify specific genes. It is through the raising and careful observation of these genetically modified animals that clues are provided about the normal function of the gene or genes in question. These types of experiments have provided valuable insight into organismal development, function of the immune and nervous systems, and metabolism. It has also allowed models of human disease to be generated. These models have been instrumental in determining the mechanism of action of new therapies for disease and have allowed preclinical testing of new therapeutic approaches. Multiple animal models have made unique contributions and invaluably aided our understanding of the various roles of the FOXO family of transcription factors.
The FOXO subfamily of FOX genes
The FOXO family of transcription factors regulates a wide variety of cellular and organismal processes both during development and in the adult. The forkhead superfamily of transcription factors shares a highly conserved 100 amino-acid DNA binding or FOX (Forkhead box) domain. The three predominant members of the mammalian Foxo subfamily of the Fox transcription factors (Foxo1, Foxo3 and Foxo4) were identified through the cloning of chromosomal translocation break points associated with cancer (reviewed by Arden, 2006) . All three Foxo factors are similarly regulated through phosphorylation by a variety of kinases, including AKT/protein kinase B (PKB), serumand glucocorticoid-inducible kinase, casein kinase 1, dual-specificity tyrosine-phosphorylated and -regulated kinase 1A and anti-I-kappa-B kinase b, typically resulting in Foxo inactivation by active nuclear export to the cytoplasm. In contrast, in response to stress stimuli, Foxo can be phosphorylated by the mitogenactivated protein kinase family member, jun N-terminal kinase (JNK), resulting in the opposite effect, the movement of Foxo from the cytoplasm to the nucleus. The AKT and JNK pathways appear to operate in opposition by regulating subcellular localization of Foxo factors using environmental cues promoting signal transduction from different pathways (reviewed in Greer and Brunet, 2005) .
The Foxos have overlapping gene expression patterns both during development and in the adult. In addition, Foxo1, Foxo3 and Foxo4 bind to the same DNA target sequence and are capable of regulating the same target genes. A fourth Foxo family member, FOXO6, whose expression is restricted to the brain, has been identified, but is more distantly related and is not regulated by subcellular localization (Jacobs et al., 2003) . Foxo1, Foxo3 and Foxo4 have been found to play important roles in variety of processes including cellular differentiation, tumor suppression, metabolism, cell cycle arrest, cell death and protection from stress. These roles have been discovered through manipulation of the genes encoding these factors in cell-based systems and in animals including Caenorhabditis elegans, Drosophila melanogaster and laboratory mice.
Caenorhabditis elegans
The round worm C. elegans is the first animal in which a FOXO ortholog was modified and the resulting phenotype was characterized. This organism offers several advantages for the study of gene function: it has a short life cycle; every animal has a specific number of cells; and much is known about how these cells contribute to the adult organism. It also has the distinction of being the first multicellular animal to have its genome sequenced.
Dauer larva formation in C. elegans is controlled by environmental cues. The word 'dauer' comes from the German meaning 'endurance' or 'duration.' C. elegans has the ability to halt development under conditions of starvation or overcrowding and to enter a dauer larval stage. This is a reversible stage of development, in which the worms develop impermeable cuticles, their metabolic rate slows down dramatically and they do not feed for up to 3 months. If nutrients become more abundant and the environment is less crowed, the worms sense the change, exit the dauer stage and complete the developmental process to become a mature adult. The FOXO ortholog, daf-16, was one of a number of genes identified as a mediator of dauer formation by studying the effects of gene mutation in C. elegans (Riddle et al., 1981) . Over a decade later, the connection between DAF-16's role in dauer formation and its role in C. elegans life span was discovered (Kenyon et al., 1993) . Daf-16 influences life span in the worm by mediating insulin-like metabolic signaling and confers life extension as well as resistance to stress (Murakami and Johnson, 1996; Lin et al., 1997; Ogg et al., 1997) . Mutations in daf-16 prevent dauer formation under the environmental conditions that normally promote dauer formation. Through additional experimentation it was determined that the insulin-like pathway in worms included two C. elegans AKT-PKB homologs that function primarily to inactivate Daf-16 providing the first evidence that a transcription factor could be a downstream target of AKT-PKB (Paradis and Ruvkun, 1998) . A search of the DAF-16 amino-acid sequence revealed three putative AKT/PKB consensus sites offering further proof that DAF-16 was regulated by the worm insulin-like signaling pathway resulting in the inactivation of DAF-16 when the insulin-like pathway is activated. It was these important observations in C. elegans and the speculation that aspects of the regulatory pathway, so elegantly dissected in worms, may be conserved in higher level organisms that set the stage for studies in higher organisms. Studies on DAF-16 in C. elegans did not end with the discovery of this regulatory mechanism. Further studies have revealed that DAF-16 regulation is complex and impacted by several additional pathways important to the biological processes of C. elegans including sensory perception, germ line signaling and JNK signaling (reviewed by Mukhopadhyay and Tissenbaum, 2007) .
Drosophila melanogaster
The fruit fly Drosophila melanogaster is another manipulable animal model system. D. melanogaster has been used for genetic experiments for over a century. One of the reasons it continues to be a valuable model animal is that much is known about how to optimally handle the flies. Similar to C. elegans, these are small animals with a relatively short life cycle of about 2 weeks. Mutant flies with defects in thousands of genes are readily available. In fact, the name 'forkhead' comes from observations of flies with mutations in the 'forkhead' gene. These flies developed ectopic head structures giving the appearance of two heads. There are established and well-understood methods for manipulating the fly genome and the entire genome has now been sequenced.
The amino-acid sequence of the D. melanogaster homolog of daf-16, dFOXO, was highly conserved when compared to DAF-16 (Kramer et al., 2003) . It was discovered that overexpression of dFOXO leads to a reduction in the size of the animal due to decreases in cell size and cell number. This phenotype was very similar to starvation, suggesting that dFOXO plays a role in nutrient sensing, similar to that observed in C. elegans (Kramer et al., 2003) . Interestingly, overexpression of dFOXO targeted to specific tissues in the fly results in a reduction in organ size by reducing cell number but does not seem to have an effect on cell size (Puig et al., 2003) . Flies lacking dFOXO appear physically normal but show increased sensitivity to oxidative stress (Ju¨nger et al., 2003) . Expression of dFOXO in the adult pericerebral at body of D. melanogaster has been shown to decrease mortality and increase life span significantly (Giannakou et al., 2004; Hwangbo et al., 2004) . dFOXO has also been shown to play a role in the control of insulin receptor (Insr). Starvation of wild-type flies upregulates Insr expression. However, flies deficient for dFOXO cannot upregulate Insr in response to starvation, suggesting that dFOXO-mediated feedback of Insr transcriptional activation is key to the feedback mechanism of controlling the regulation of insulin signaling (Puig and Tjian, 2005) .
It should be noted that information related to the function of Foxo can be gained from genetic alteration of other genes that have an effect on Foxo. Although this is not the focus of this article, one such example in Drosophila is the manipulation of the insulin/insulin growth factor-like signaling pathway using an inducible expression system (Giannakou et al., 2007) . When this pathway is altered, dFOXO levels also change. This effect lessens with age, suggesting that some process exists that prevents or lessens the physiological response to changes in insulin/insulin growth factor-like signaling pathway as the organism ages.
Mouse
Although C. elegans and D. melanogaster have many characteristics that make them useful model systems, many useful discoveries are still to be made in these nonmammalian systems. However, to be useful and relevant to the human condition, these discoveries must be validated in the context of the more complex mammalian system. The laboratory mouse (Mus musculus) has become the premier mammalian model system for genetic research. Much is known about the mouse genome, and there are clear genetic similarities to the human genome. Humans and mice are also physiologically similar. Parallels can be drawn between the human and mouse immune, nervous and cardiovascular systems to name just a few. Mice also develop some of the same conditions seen in humans such as cancer, hypertension, diabetes and osteoporosis. There exist well-known methods to manipulate the mouse genome. The mouse is fairly small, which is important when calculating experimental costs and, relative to other mammalian species, mice have a short life span and reproduce fairly quickly. Foxo genes have been genetically modified in a number of mouse models. These models have been instrumental in furthering our understanding of the multiple roles occupied by the various Foxo transcription factors.
The results of experiments conducted in C. elegans and D. melanogaster model systems suggested that Foxo factors might play a role in signaling downstream from the insulin receptor in mammals. The first experiments using a genetically modified mouse model for Foxo used a mouse deficient for one allele of Foxo1 (Foxo1 . Breeding these mice with insulinresistant diabetic mice, caused by a mutation in Insr, resulted in restored insulin sensitivity and a rescue of the diabetic phenotype. This result was achieved through downregulation of glucogenetic gene expression in the liver and coordinate upregulation of insulin-sensitizing genes. This initial study suggested that Foxo1 has a role as a negative regulator of insulin sensitivity. The role of pancreatic b cells is integral to diabetes. Type 1 diabetes is characterized by the complete absence of insulinproducing b cells, whereas type II diabetes is associated with a deficiency of insulin-producing b cells. Foxo1 haploinsufficiency reversed the characteristic b-cell failure observed in mice lacking Insr substrate-2 (Irs2
) by partial restoration of the ability of the residual b cells to proliferate and increased expression of Pdx1 . These data suggest that Foxo1 is an important regulator of b-cell proliferation. Insulin promotes cellular relocalization of Foxo1 to the cytoplasm thereby interfering with Foxo1 inhibition of Pdx1 expression and promoting b-cell proliferation. Foxo1 haploinsufficiency has also been shown to confer protection from diet-induced diabetes in mice. These mice have reduced levels of cytokines known to be associated with insulin resistance (serum tumor necrosis factor-a and resistin) (Nakae et al., 2003) .
In a study of hepatic stellate cells (HSCs) and liver fibrosis, inactivation of Foxo1 promotes proliferation and transdifferentiation of HSCs resulting in the increase in susceptibility of Foxo1 þ /À mice to experimentally induced liver fibrosis (Adachi et al., 2007) . Hyperinsulinemia inactivates Foxo1 in HSCs, resulting in HSC activation, proliferation and transdifferentiation, and may contribute to the fibrosis observed in nonalcoholic fatty liver disease.
All of the experiments in mice detailed above had to be conducted using the Foxo1 þ /À mouse, because the Foxo1-null (Foxo À/À ) state results in an embryonic lethal phenotype. However, transgenic mice have been created that overexpress wild-type Foxo. Transgeneic mice that express Foxo1 targeted to skeletal muscle exhibit a reduction in skeletal muscle mass, glycemic control and expression of slow twitch/red muscle fiber (Kamei et al., 2004) . The creation of transgenic mice expressing a mutated Foxo1 cDNA, bearing a single amino-acid substitution replacing the phosphorylatable Ser253 with the nonphosphorylatable amino-acid alanine, results in a constitutively nuclear/constitutively active form of Foxo1. The constitutively active form of Foxo1, when expressed from a transgene containing a promoter that targeted expression to the liver and pancreatic b cells, resulted in mice that developed glucose intolerance, b-cell failure and diabetes in an age-dependent manner, lending further support to a role for Foxo1 as an important downstream regulator of the insulin pathway and suggesting that Foxo1 could be a useful therapeutic target in the treatment of diabetes .
As mentioned above, Foxo1-null embryos die during embryonic development. Death takes place on embryonic day 10.5 as a consequence of incomplete vascular development. Foxo1 À/À embryos are approximately 50% the size of their Foxo1 þ / þ littermates. Cardiac looping of Foxo1 À/À embryos is retarded and the pericardium is distended compared to Foxo1 þ / þ and Foxo1
. The dorsal aorta in Foxo1 À/À embryos appears thin and disorganized, and the intersomitic vessels are also irregularly developed. The head vasculature of Foxo1 À/À embryos also appears to lack properly formed branches of the internal carotid artery. In addition, developed vasculature was not present in Foxo1 À/À yolk sacs. Foxo1 expression was found in a variety of embryonic vessels, supporting a crucial role of this transcription factor in vascular formation (Hosaka et al., 2004) . In vitro differentiation of embryonic stem cells demonstrated that endothelial cells derived from Foxo1-deficient embryonic stem cells in the absence of exogenous vascular endothelial growth factor showed a markedly different morphological response compared with wild-type endothelial cells, suggesting that Foxo1 is important in endothelial cell response to vascular endothelial growth factor (Furuyama et al., 2004) . Thus, in the developing embryo, Foxo1 plays a critical role in establishing normal vasculature.
Both Foxo3a-and Foxo4-null mice are viable and grossly indistinguishable from their littermate controls, indicating dispensability of these two members of the Foxo transcription factor family for normal vascular development. Foxo3-null female mice showed agedependent infertility and had abnormal ovarian follicular development (Castrillon et al., 2003; Hosaka et al., 2004) . The Foxo3 À/À female mice exhibit widespread, almost uniform follicular activation leading to oocyte degeneration, resulting in the early total depletion of functional ovarian follicles by 12 weeks of age and infertility. Foxo3 appears to function normally to suppress follicular activation and help maintain a reserve resting follicle pool. The increased levels of serum follicle-stimulating hormone and luteinizing hormone levels in Foxo3 À/À female mice suggest that this phenotype may be very similar to accelerated follicular initiation and ultimate follicle depletion observed in human premature ovarian failure, a common cause of infertility and premature aging in women (Castrillon et al., 2003) .
Foxo3 is the predominant Foxo member expressed in peripheral lymphoid organs. Histological examination of different tissues in Foxo3-deficient mice revealed that Foxo3 deficiency leads to lymphoproliferation, widespread organ inflammation (Lin et al., 2004) . Compared to their wild-type counterparts, Foxo3 À/À hyperactivated helper T cells proliferated more vigorously and produced more Th1 and Th2 cytokines. Normally, Foxo3 inhibits NF-kB activation. Therefore, in the absence of Foxo3, activation of NF-kB promotes T-cell hyperactivity. In a role seemingly unrelated to ovarian function, Foxo3 regulates helper T-cell activation by inhibiting NF-kB activity, suggesting a role for the Foxo proteins in the inhibition of inflammation.
In contrast, to the Foxo1-and Foxo3-deficient mice, Foxo4-null mice are grossly normal in appearance, and histological analysis of over 30 tissues from 9-week-old Foxo4 À/À mice compared to their normal counterparts revealed no consistent histological differences (Hosaka et al., 2004) . The important conclusion from these individual gene disruption experiments is that the physiological roles of Foxo factors are functionally diverse in mammals.
The experiments described above relied on the constitutive individual disruption of each of the three predominant Foxo genes. Individual gene disruption resulting in differing phenotypes suggests that some degree of functional diversification exists during development and in the adult animal (Castrillon et al., 2003; Hosaka et al., 2004) When Cre-mediated gene disruption of all three Foxo genes was induced at 4-5 weeks of age, the animals developed lymphoblastic thymic lymphomas between 19 and 30 weeks of age. These tumors possessed the ability to spread to additional tissues (spleen, liver and lymph nodes) (Paik et al., 2007) . The Foxo1-, Foxo3-, Foxo4-null mice also developed hemangiomas first appearing in the uterus at 6-8 weeks of age. The hemangiomas eventully progressed to massive fatal tumors found in skeletal muscle, abdominal wall, liver, adrenal glands, bone marrow, omentum, lymph nodes and skin. Lethal angiosarcomas were observed in 9% of the animals. Functional redundancy of Foxo genes was apparent, as loss of all three Foxo alleles was required for the tumor phenotype. Disruption of any combination of two of the three Foxo genes resulted in a more moderate phenotype. Thus, the functional redundancy of these closely related transcription factors was confirmed.
In light of the widespread tissue distribution of Foxo expression in mammals, the restricted tumor phenotype was unexpected. In humans, individual FOXO gene disruption by chromosome translocation has been associated with leukemia and the solid tumor, alveolar rhabdomyosarcoma, whereas misregulation of FOXO genes has been associated with a variety of tumor types including prostate, stomach, brain and breast. As the FOXO DNA-binding domain is disrupted by the chromosomal translocations, thereby eliminating regulation of its target genes, it has been proposed that Foxos may function as tumor suppressors. Activation of Foxo factors by mutation of the phosphorylation sites, thereby restricting the localization of the Foxo proteins to the nucleus, results in cell-cycle arrest or cell death as would be expected of a tumor suppressor gene. Furthermore, all three predominant Foxo factors are directly regulated by AKT and a variety of tumor types are associated with mutations affecting the PI3K/AKT pathway. It was surprising therefore that, despite the absence of Foxo proteins in several cell and tissue types where Foxos are normally expressed, the tumor phenotype was restricted to endothelial-derived cells. Perhaps more interesting, not all tissues containing endothelial cells were affected. For example, lungs and kidneys were unaffected, suggesting that the phenotype is not only cell lineage restricted but also organ-specific. Foxo-deficient liver-derived endothelial cells show an increased capacity for proliferation and survival. These characteristics were absent in Foxo-deficient endothelial cells derived from lung tissue. Microarray analysis revealed nonoverlapping lists of putative direct targets when RNA from liver-derived Foxo-deficient endothelial cells was compared to Foxo-deficient thymocytes further reinforcing the concept of Foxo cell-and tissue-type specificity.
Oxidative stress is implicated in the etiology of many human diseases and Foxos have been implicated as important mediators of cellular response to oxidative stress (Kops et al., 2002) . Using the same system of Cremediated disruption of all three Foxo genes but focusing on the hematopoietic system revealed a significant decrease in the long-term hematopoietic stem cell population and the common lymphoid progenitor compartment (Tothova et al., 2007) . The Foxo-deficient bone marrow was found to be defective in colony-formation activity in vitro and in its ability to support long-term bone marrow repopulation in vivo. A significant increase in the number of HSCs exiting G 0 /G 1 and entering S/G 2 /M was observed, suggesting that Foxos are important in maintaining the quiescent state of HSCs and preserving their replicative and renewal capacity. This is reminiscent of the role of Foxo3 in maintaining a resting pool of ovarian follicles. Foxo-deficient HSCs also exhibit increased levels of apoptosis further contributing to the overall decrease in cell number. Similar to the tumor phenotype described above, deficiency in any one or two Foxo genes in combination does not produce the full cell cycle and apoptosis phenotype corroborating the functional redundancy of Foxo proteins. A marked increase in reactive oxygen species levels in HSC isolated from the Foxo-deficient mice was also observed. Gene expression analysis revealed a decrease in expression of a subset of genes associated with cellular response to oxidative stress, suggesting that the increase in reactive oxygen species detected in the Foxo-deficient HSCs is due to a deficiency in gene products required for the detoxification of reactive oxygen species.
Conclusion
The animal models discussed above illustrate the value of studying conserved pathways in a variety of model systems. The shared effects of Foxo gene deficiency are significant. Consistent across all model systems was the role of Foxo in the insulin-signaling pathway. In addition, Foxo appears to be important in the maintenance of quiescent cells. This role applies to a variety of setting from long-term hematopoietic stem cell population, HSCs and ovarian follicles in mammals to the quiescent stage of the dauer larval stage in C. elegans. The animal model systems developed and studies to date have revealed much about the multiple roles of Foxo factors at the complex organismal level; however, many questions remain to be explored. Unraveling the multifaceted aspects of FOXO regulation will provide important insights of all the processes involving Foxos including development, immunity, neurology, physiology, metabolism and aging.
